RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Focus Forward: Invest in Yourself, Invest in Your Staff

Focus Forward: Invest in Yourself, Invest in Your Staff

Posted 01 April 2010 | By

A few weeks ago, the Tufts University Center for the Study of Drug Development released findings from its study on drug development and biotechnology organizations. The group's conclusions: "The growing volume of global drug development and commercialization activity during the past decade dramatically increased the workload for regulatory affairs professionals at pharmaceutical and biotech companies. " The Tufts study reported that regulatory professionals support an average of 100 projects per year, are often more experienced than their peers in other areas and have longer tenure with the organization. The study also indicated that challenges for regulatory professionals are likely to increase while their role will be even more critical.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.